PL369469A1 - Heterokarpina, białko wiążące ludzki GHRH - Google Patents

Heterokarpina, białko wiążące ludzki GHRH

Info

Publication number
PL369469A1
PL369469A1 PL02369469A PL36946902A PL369469A1 PL 369469 A1 PL369469 A1 PL 369469A1 PL 02369469 A PL02369469 A PL 02369469A PL 36946902 A PL36946902 A PL 36946902A PL 369469 A1 PL369469 A1 PL 369469A1
Authority
PL
Poland
Prior art keywords
binding protein
heterocarpine
ghrh
human ghrh
human
Prior art date
Application number
PL02369469A
Other languages
English (en)
Other versions
PL207581B1 (pl
Inventor
Eric Ferrandis
Beng Poon Teng
Christine Sohier
Christophe Thurieau
Original Assignee
Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) filed Critical Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.)
Publication of PL369469A1 publication Critical patent/PL369469A1/pl
Publication of PL207581B1 publication Critical patent/PL207581B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Botany (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL369469A 2001-02-27 2002-02-26 Izolowane białko otrzymywane przez ekstrakcję z rośliny Pilocarpus heterophyllus i jego zastosowania, przeciwciało monoklonalne lub jego fragment wiążący antygen, kompozycja farmaceutyczna oraz sposób ekstrakcji i izolacji heterokarpiny z komórek rośliny Pilocarpus heterophyllus PL207581B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0102631A FR2821359B1 (fr) 2001-02-27 2001-02-27 L'heterocarpine, une proteine fixant le ghrh humain
PCT/FR2002/000691 WO2002068461A2 (fr) 2001-02-27 2002-02-26 L'heterocarpine, une proteine fixant le ghrh humain

Publications (2)

Publication Number Publication Date
PL369469A1 true PL369469A1 (pl) 2005-04-18
PL207581B1 PL207581B1 (pl) 2011-01-31

Family

ID=8860481

Family Applications (1)

Application Number Title Priority Date Filing Date
PL369469A PL207581B1 (pl) 2001-02-27 2002-02-26 Izolowane białko otrzymywane przez ekstrakcję z rośliny Pilocarpus heterophyllus i jego zastosowania, przeciwciało monoklonalne lub jego fragment wiążący antygen, kompozycja farmaceutyczna oraz sposób ekstrakcji i izolacji heterokarpiny z komórek rośliny Pilocarpus heterophyllus

Country Status (20)

Country Link
US (1) US7385024B2 (pl)
EP (1) EP1409531B1 (pl)
JP (1) JP4117194B2 (pl)
KR (1) KR20030094262A (pl)
CN (1) CN100340573C (pl)
AT (1) ATE309269T1 (pl)
AU (1) AU2002241065B2 (pl)
BR (1) BR0207578A (pl)
CA (1) CA2437516A1 (pl)
CZ (1) CZ20032612A3 (pl)
DE (1) DE60207257T2 (pl)
ES (1) ES2252431T3 (pl)
FR (1) FR2821359B1 (pl)
HU (1) HU225431B1 (pl)
IL (2) IL157150A0 (pl)
MX (1) MXPA03007626A (pl)
NZ (1) NZ527749A (pl)
PL (1) PL207581B1 (pl)
RU (1) RU2305683C2 (pl)
WO (1) WO2002068461A2 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2843697B1 (fr) * 2002-08-26 2005-12-09 Sod Conseils Rech Applic L'heterocarpine, une proteine d'origine vegetale aux proprietes anticancereuses
US7494969B2 (en) 2002-02-26 2009-02-24 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Heterocarpine, a plant-derived protein with anti-cancer properties
US20060128615A1 (en) * 2002-09-18 2006-06-15 Pierrette Gaudreau Ghrh analogues
FR2848221B1 (fr) 2002-12-10 2007-09-28 Sod Conseils Rech Applic Procede de preparation d'heterocarpine recombinante
JP2005289895A (ja) * 2004-03-31 2005-10-20 Kagoshima Tlo Co Ltd 植物タンパク質分離精製法及びそれに用いるタンニン中和剤並びにその調製法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5550212A (en) * 1993-12-17 1996-08-27 The Administrators Of The Tulane Educational Fund Analogues of hGH-RH(1-29)NH2 having antagonistic activity
EP0674007B1 (fr) * 1994-03-21 1999-07-21 Societe Des Produits Nestle S.A. Procédé de production de pilocarpine
US20050160088A1 (en) 2001-05-17 2005-07-21 Todd Scallan System and method for metadata-based distribution of content

Also Published As

Publication number Publication date
HU225431B1 (en) 2006-11-28
EP1409531A2 (fr) 2004-04-21
HUP0303244A2 (hu) 2003-12-29
RU2305683C2 (ru) 2007-09-10
WO2002068461A2 (fr) 2002-09-06
US7385024B2 (en) 2008-06-10
CZ20032612A3 (cs) 2004-08-18
CA2437516A1 (fr) 2002-09-06
PL207581B1 (pl) 2011-01-31
JP4117194B2 (ja) 2008-07-16
EP1409531B1 (fr) 2005-11-09
IL157150A0 (en) 2004-02-08
BR0207578A (pt) 2004-03-02
US20040063621A1 (en) 2004-04-01
WO2002068461A3 (fr) 2004-02-12
FR2821359B1 (fr) 2003-05-09
ATE309269T1 (de) 2005-11-15
JP2004538254A (ja) 2004-12-24
NZ527749A (en) 2006-09-29
RU2003128963A (ru) 2005-02-20
CN100340573C (zh) 2007-10-03
AU2002241065B2 (en) 2006-09-28
KR20030094262A (ko) 2003-12-11
FR2821359A1 (fr) 2002-08-30
DE60207257T2 (de) 2006-07-27
IL157150A (en) 2008-11-26
DE60207257D1 (de) 2005-12-15
ES2252431T3 (es) 2006-05-16
HUP0303244A3 (en) 2005-11-28
CN1531550A (zh) 2004-09-22
MXPA03007626A (es) 2003-12-04

Similar Documents

Publication Publication Date Title
WO2003099771A3 (en) Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
WO2002085299A3 (en) Therapeutic treatments using the direct application of antimicrobial metal compositions
WO2003096990A3 (en) Protein cages for the delivery of medical imaging and therapy
IL164135A (en) 4-anilino quinazoline derivatives as antiproliferative agents, process for their preparation, pharmaceutical compositions containing such derivatives and use thereof for the preparation of medicaments for the treatment of cancer
WO2004005326A3 (de) Tubulysinkonjugate
MXPA04003796A (es) Tioacetamidas sustituidas.
DE60233803D1 (de) 5-cnac zur oralen verabreichung von parathormonfragmenten
AU2003297199A8 (en) Human chondroitinase glycoprotein (chasegp), process for preparing the same, and pharmaceutical compositions comprising thereof
WO2003039539A3 (de) Verwendung von endothelin-rezeptor-antagonisten zur behandlung von tumorerkrankungen
IL157150A0 (en) Heterocarpine, a human ghrh-binding protein
TNSN04235A1 (en) Compositions for therapeutic use comprising a vitamin, a metal salt and insulin or a growth hormone
DK1343472T3 (da) Thixotropisk næsespray
UA83989C2 (ru) Выделенный пептид, который стимулирует противоопухолевый иммунный ответ, фармацевтическая композиция на его основе и ее применение
WO2004017987A3 (fr) L'heterocarpine, une proteine d'origine vegetale aux proprietes anticancereuses
HUP0401589A3 (en) New peptides - analogs of human growth hormone-releasing hormone
PT1406859E (pt) Derivados substituídos de 4-aminociclo-hexanol
WO2003080800A3 (en) Prevention and treatment of disease using angiogenesis-and/or tumor antigens
MXPA03006626A (es) Formulacion de la goma para el tratamiento de la semilla de plantas.
WO2005120540A3 (en) Interferon alpha or beta for treatment of cardiomyopathy and endothelial dysfunction
WO2002100317A3 (en) Targeted particles and methods of using the same
WO2003040119A8 (fr) Inhibiteurs de l'angiogenese
UA34265A (uk) Паста для лікування захворювань тканин пародонту
MXPA05003633A (es) 2"-oxo-voruscharina y derivados de la misma.
UA83988C2 (ru) Моноклональное антидвойное интегриновое антитело, которое специфически связывает человеческие интегрины альфа v бета 3 и альфа v бета 5, фармацевтическая композиция, которая его содержит, и их применение в терапии
EP1408043A8 (en) 2''oxo-voruscharin and analogues thereof